Guggenheim vs. Other EBs
How does the reputation/exit opps of Guggenheim Securities compare with other elite boutiques? What is the typical pecking order of EBs in terms of the aforementioned qualities? Thanks.
Trending Content
Career Resources
WSO Free Modeling Series - Now Open Through
May 31, 2024
9 Free Financial Modeling Lessons
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
+Bonus: Get 27 financial modeling templates in swipe file
+Bonus: Get 27 financial modeling templates in swipe file
Gugg is sometimes considered EB and sometimes MM mostly due because depending on the group it varies who it is competing against / what level it’s at
No matter how much the nerds try and astroturf it here, Gugg is not an EB.
It is a Jeff/Leerink/Cowen type bank. Nothing wrong with that, but not the same as the traditional EBs.
I feel like people think of it like an eb because of how much they pay.
https://www.factset.com/hubfs/mergerstat_em/monthly/US-Flashwire-Monthl…
Doesn't this data seem to imply Gugg is on the higher tier, at least in terms of deal volume, of the EBs? Does perception not live up this fact and for that reason it's considered sub-par?
So Guggenheim has greater deal value than Moelis and Lazard, has more deals than PJT and PWP, they pay near top of Street... sounds like EB to me. Clearly getting good-sized deals, also getting the deal volume so that analysts get reps... why wouldn't they be deemed comparable to these other firms?
Very group-dependent, HCS/Biopharma/TMT/RX/SPO are really strong groups, some others are decent and some aren't great.
But isn't that the case with most EBs? I mean, you named 5 strong groups -- do other EBs have more, or have 100% strong groups all across the board?
Good point, my guess would be (and take this with a grain of salt, I'm not super knowledgable about the space) that they are a relatively new bank and had a slow ramp-up period even with the strong groups (Gugg RX pre and post Millstein acquisition were very different). Seems like kids from those groups can exit really well within their industry/product but there isn't that "5-10+ years of greatness" rep that seems to be common with a lot of the EBs, so kids aren't really going to MF PE. Seems like older posts here and league tables would agree that Guggenheim wasn't putting up similar results in 2015/2016/2017. Maybe the large analyst classes also dilute the talent pool a bit. Again, not really sure, just thinking out loud
At aut fuga et enim voluptas. Et iure dolores nostrum hic numquam nemo. Et et explicabo eligendi nam corporis est repudiandae dolores. Assumenda quos molestiae est iste laborum id. Ratione eligendi eum soluta fuga odit. Laborum amet ab quae.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...